FDA Inspections Of Foreign Device Manufacturers Anemic – GAO Testimony
This article was originally published in The Gray Sheet
Executive Summary
FDA's effectiveness in conducting device manufacturing inspections overseas was criticized by the Government Accountability Office in testimony before Congress that found overall "weaknesses" in the agency's inspection of medical device manufacturers
You may also be interested in...
FDA Lacks Methodology To Determine Budgetary Needs, GAO Report Finds
According to a Government Accountability Office report released July 20, FDA not only lacks resources, but the agency has no credible method for determining the exact funding it needs
FDA Lacks Methodology To Determine Budgetary Needs, GAO Report Finds
According to a Government Accountability Office report released July 20, FDA not only lacks resources, but the agency has no credible method for determining the exact funding it needs
FDA Can’t Inspect Its Way Out Of Import Safety Problems – Schultz, Sharfstein
Increasing the number of foreign device facility inspections alone will not dramatically improve FDA import safety, agency leaders say